Immunotherapy With Nivolumab in Combination With Lenvatinib for Advanced Stage Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Feasibility and Tolerance of Nivolumab Neoadjuvant Immunotherapy in High Risk HPV Driven Oropharynx Cancer
- Status
- COMPLETED
- Phase
- PHASE2
NADIM II: Neo-Adjuvant Immunotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Microsatellite Stable, MGMT Silenced Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES)
- Status
- TERMINATED
- Phase
- PHASE2
Evaluate the Clinical Benefit of a Post-operative Treatment Associating Radiotherapy + Nivolumab + Ipilimumab Versus Radiotherapy + Capecitabine for Triple Negative Breast Cancer Patients With Residual Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention
- Status
- COMPLETED
- Phase
- PHASE1
Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Status
- RECRUITING
- Phase
- PHASE1
Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO
- Status
- RECRUITING
- Phase
- PHASE2
Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Nivolumab Based Immunotherapy for Treatment of High Grade Cervical Dysplasia
- Status
- WITHDRAWN
- Phase
- PHASE2